Ratings by William Blair (Alethia Young)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | Kardigan Inc | KARD | New Coverage | Outperform (N/A) |
13.52 (12.71) |
-5.99% | Details | |
| 10/16/2026 | Arcus Biosciences | RCUS | New Coverage | Outperform (N/A) |
22.53 (19.56) |
-13.18% | Details | |
| 10/16/2026 | Faeth Therapeutics | FTH | New Coverage | Outperform (N/A) |
20.00 (20.64) |
3.2% | Details | |
| 10/16/2026 | Rhythm Pharmaceuticals | RYTM | New Coverage | Outperform (N/A) |
86.71 (88.55) |
2.12% | Details | |
| 10/16/2026 | WAVE Life Sciences | WVE | New Coverage | Outperform (N/A) |
3.09 (3.38) |
9.39% | Details | |
| 10/16/2026 | Palvella Therapeutics | PVLA | New Coverage | Outperform (N/A) |
122.58 (126.34) |
3.07% | Details | |
| 10/16/2026 | Ideaya Biosciences | IDYA | New Coverage | Outperform (N/A) |
33.86 (35.39) |
4.52% | Details | |
| 10/16/2026 | Immunome Inc. | IMNM | New Coverage | Outperform (N/A) |
17.20 (17.97) |
4.48% | Details | |
| 10/16/2026 | Revolution | RVMD | New Coverage | Outperform (N/A) |
193.52 (194.66) |
0.59% | Details | |
| 10/15/2026 | Tango Therapeutics Inc. | TNGX | New Coverage | Outperform (N/A) |
22.19 (26.76) |
20.59% | Details | |
| 10/15/2026 | Cytokinetics | CYTK | New Coverage | Outperform (N/A) |
63.43 (62.66) |
-1.21% | Details |
